ScreenerHero
VTRVentas, Inc.
NYSE · US · Real Estate · REIT - Healthcare Facilities · ventasreit.com
93.73USD+2.05%Mkt Cap: 47.11B $P/E: 167.00

Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an esse…

Industry Peers

REIT - Healthcare Facilities
Screen all
WELL
Welltower Inc.
$169.86BUSDP/E 105.2
OHI
Omega Healthcare Investors, Inc.
$14.80BUSDP/E 16.7
DOC
Healthpeak Properties, Inc.
$14.72BUSDP/E 59.3
CTRE
CareTrust REIT, Inc.
$9.41BUSDP/E 24.9
HR
Healthcare Realty Trust Incorporated
$6.78BUSD
AED
Aedifica NV/SA
$6.20BUSDP/E 5.9
SBRA
Sabra Health Care REIT, Inc.
$5.25BUSDP/E 79.0
CSH-UN
Chartwell Retirement Residences
$5.06BUSDP/E 1054.0
NHI
National Health Investors, Inc.
$3.64BUSDP/E 21.4
PHP
Primary Health Properties Plc
$2.72BUSDP/E 16.1
MPT
Medical Properties Trust Inc. common stock
$2.48BUSD
LTC
LTC Properties, Inc.
$2.17BUSDP/E 14.4
DHC
Diversified Healthcare Trust
$1.96BUSD
SILA
Sila Realty Trust Inc. Common Stock
$1.68BUSDP/E 44.6
STRW
Strawberry Fields REIT Inc. Common Stock
$769.23MUSDP/E 20.9
NHP
National Healthcare Properties Inc. Class A Common Stock
$747.36MUSD
CPINV
Care Property Invest NV
$556.90MUSDP/E 8.0
UHT
Universal Health Realty Income Trust
$571.24MUSDP/E 29.6
XRN
Chiron Real Estate Inc. Common Stock
$533.88MUSDP/E 9.9
CHCT
Community Healthcare Trust Incorporated
$422.58MUSDP/E 22.1

Key Statistics

Company
Market Cap47.11B $
Enterprise Value60.82B $
Revenue (TTM)6.42B $
Gross Profit2.41B $
Net Income (TTM)251.38M $
Revenue/Share13.56 USD
Last Price93.73 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees542
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINUS92276F1003
Valuation
P/E (Trailing)167.00
P/E (Forward)101.29
PEG1.72
EV/EBITDA25.55
EV/Revenue9.48
P/S7.41
P/B3.25
EPS (TTM)0.56
EPS (Forward)0.92
52W Range
66.3878% of range101.60
52W High101.60 USD
52W Low66.38 USD
Profitability
Gross Margin41.38%
Oper. Margin14.81%
EBITDA Margin37.09%
Profit Margin4.31%
ROE2.01%
ROA0.91%
Growth
Revenue Growth21.70%
Earnings Growth-6.70%
Cash Flow & Leverage
Operating CF1.65B $
CapEx (TTM)644.62M $
FCF Margin23.16%
FCF Yield3.16%
Net Debt12.72B $
Net Debt/EBITDA5.34
Balance Sheet
Debt/Equity1.06
Current Ratio0.29
Quick Ratio0.26
Book Value/Sh28.56 USD
Cash/Share0.3880 USD
Dividends
Fwd Div Rate2.000 USD
Trail. Div Rate2.000 USD
Div. Yield2.18%
5Y Avg Yield3.31%
Payout Ratio363.64%
Ex-Div DateJun 30, 2026
Pay DateJul 16, 2026
Splits
Last Split8757:10000
Split DateAug 18, 2015
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)100.45 USD
Upside (mean)+7.2%
Target Range86.00 USD – 113.00 USD
$86.00+7.2% to mean$113.00
# Analysts22
Ownership
Shares Out.512.95M
Float510.53M
Insiders0.51%
Institutions105.06%
Short Interest
Short Ratio6.4d
Short % Float5.29%
Short % Out.4.61%
Shares Short23.67M
Short (prev mo.)22.80M
Technical
SMA 5091.04 (+3.0%)
SMA 20084.28 (+11.2%)
Beta0.73
S&P 52W Chg18.16%
Avg Vol (30d)2.31M
Avg Vol (10d)3.16M
Technical Indicators
RSI (14)49.6
MACD-0.4292
MACD Signal-0.0070
MACD Hist.-0.4222
BB Upper101.05 USD
BB Middle93.48 USD
BB Lower85.91 USD
BB Width16.20%
ATR (14)2.237 USD
Vol Ratio (20d)0.57x